Skip to content
Logo gov.co
Logo Redcol
  • Inicio
  • La Red
    • Quiénes Somos
    • Objetivos
    • Historia de la Red
    • ¿Cómo ser parte de la red?
    • Contacto
  • Servicios
    • Cursos y Talleres
    • Recursos
    • Colecciones Especializadas
    • Destacados

Contraste

Aumentar letra

Reducir letra

Centro de relevo

  • Home
  • Evaluation of the immune respo...
  • Cite this
  • Text this
  • Email this
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote

Evaluation of the immune response to human papillomavirus types 16, 18, 31, 45 and 58 in a group of Colombian women vaccinated with the quadrivalent vaccine

 

Authors
Cómbita, Alba; Duarte, Diego; Rodríguez, Josefa; Molano, Mónica; Martínez, Lina; Romero, Pilar; Trujillo, Lina; González, Mauricio; Luna, Joaquín; Ortiz, Natascha; Hernández, Gustavo; Coursaget, Pierre; Touzé, Antoine
Format
Article
Status
Published version
Description

Publication Year
2013
Language
English
Topic
Vacunas contra Papillomavirus
Inmunidad
Seroprevalencia
Papillomavirus Vaccines
Immunity
Seroprevalence
Repository
Repositorio EdocUR - U. Rosario
Get full text
https://doi.org/10.1016/s0123-9015(13)70012-x
https://repository.urosario.edu.co/handle/10336/25859
Rights
Open access
License
Abierto (Texto Completo)

Similar Items

  • Ault K.A.; Joura E.A. Kjaer S.K. Iversen O.-E. Wheeler C.M. Perez G. Brown D.R. Koutsky L.A. Garland S.M. Olsson S.-E. Tang G.W.K. Ferris D.G. Paavonen J. Steben M. Bosch F.X. Majewski S. Muñoz N. Sings H.L. Harkins K. Rutkowski M.A. Haupt R.M. Garner E.I.O. (2011) Adenocarcinoma in situ and associated human papillomavirus type distribution observed in two clinical trials of a quadrivalent human papillomavirus vaccine

  • Muñoz, Nubia; Kjaer, Susanne K. Sigurdsson, Kristján Iversen, Ole-Erik Hernandez-Avila, Mauricio Wheeler, Cosette M. Perez, Gonzalo Brown, Darron R. Koutsky, Laura A. Tay, Eng Hseon Garcia, Patricía J. Ault, Kevin A. Garland, Suzanne M. Leodolter, Sepp Olsson, Sven-Eric Tang, Grace W. K. Ferris, Daron G. Paavonen, Jorma Steben, Marc Bosch, F. Xavier Dillner, Joakim Huh, Warner K. Joura, Elmar A. Kurman, Robert J. Majewski, Slawomir Myers, Evan R. Villa, Luisa L. Taddeo, Frank J. Roberts, Christine Tadesse, Amha Bryan, Janine T. Lupinacci, Lisa C. Giacoletti, Katherine E. D. Sings, Heather L. James, Margaret K. Hesley, Teresa M. Barr, Eliav Haupt, Richard M. (2010) Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women

  • Garland, Suzanne M.; Kjaer, Susanne K. Muñoz, Nubia Block, Stan L. Brown, Darron R. DiNubile, Mark J. Lindsay, Brianna R. Kuter, Barbara J. Perez, Gonzalo Dominiak-Felden, Geraldine Saah, Alfred J. Drury, Rosybel Das, Rituparna Velicer, Christine. (2016) Impact and effectiveness of the quadrivalent human papillomavirus vaccine: A systematic review of 10 years of real-world experience

  • Brown, Darron R; Kjaer, Susanne K Sigurdsson, Kristján Iversen, Ole-Erik Hernandez-Avila, Mauricio Wheeler, Cosette M Perez, Gonzalo Koutsky, Laura A Tay, Eng Hseon Garcia, Patricía Ault, Kevin A Garland, Suzanne M. Leodolter, Sepp Olsson, Sven-Eric Tang, Grace W K Ferris, Daron G. Paavonen, Jorma Steben, Marc Bosch, F Xavier Dillner, Joakim Joura, Elmar A. Kurman, Robert J Majewski, Slawomir Muñoz, Nubia Myers, Evan R Villa, Luisa L Taddeo, Frank J Roberts, Christine Tadesse, Amha Bryan, Janine Lupinacci, Lisa C Giacoletti, Katherine E D Sings, Heather L James, Margaret Hesley, Teresa M Barr, Eliav. (2009) The impact of quadrivalent human papillomavirus (HPV; Types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years

  • Clark, Liana R.; Myers, Evan R. Huh, Warner Joura, Elmar A. Paavonen, Jorma Perez, Gonzalo James, Margaret K. Sings, Heather L. Haupt, Richard M. Saah, Alfred J. Garner, Elizabeth I.O. (2013) Clinical trial experience with prophylactic human papillomavirus 6/11/16/18 vaccine in young black women

 
logo
logo co

Ministerio de Ciencia Tecnología e Innovación

Dirección: Avenida Calle 26 No. 57 – 83 Torre 8 - Pisos del 2 al 6
Código Postal: 111321
Horario de Atención: Lunes a Jueves 8:00am - 5:00pm y Viernes 7:00am- 4:00pm (Jornada contínua).

  • Twitter
  • Youtube
  • Facebook

Contacto

Teléfono Conmutador: +(57) (1) 6258480 ext. 2081
Línea Gratuita: 01-800-0914446
Correo Institucional: atencionalciudadano@minciencias.gov.co
Correo de notificaciones judiciales:
notificacionesjudiciales@minciencias.gov.co
Política de seguridad de la información

logo
logo co
Loading...